FTH
Faeth Therapeutics, Inc.
Set alert
18.69 USD -0.06 -0.32%
17.88 Day range 19.04
7.89 52-week range 40.05
- YTD
- +75.16%
- 1 year
- +97.78%
- Open
- 18.56
- Prev close
- 18.75
- Mkt cap
- 482.96M
- Vol
- 510.97K
- Avg vol
- 370.25K
- EPS
- -60.86
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 17.88
- High
- 19.04
- Forward P/E
- -7.88
- Beta
- -0.28
- Short ratio
- 3.64
- Inst. own
- 78.84%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 13, 2026
- 50-d avg
- 30.99
- 200-d avg
- 22.28
- 1y target
- 54.64
Financial health
Altman Z-Score
11.27 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
B-3 / 5 overall
- DCF 3
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 4
- P/E 1
- P/B 5
Valuation
P/E -0.6×
FY 2018 5y median -0.6× FY 2025
P/S 0.0×
FY 2018 5y median 0.0× FY 2025
P/B 0.7×
FY 2018 5y median 0.4× FY 2025
P/FCF -0.7×
FY 2018 5y median -0.7× FY 2025
EV/EBITDA -0.3×
FY 2018 5y median -0.4× FY 2025
EV/Sales 0.0×
FY 2018 5y median 0.0× FY 2025
FCF Yield -152.2%
FY 2018 5y median -152.2% FY 2025
Profitability
Gross Margin 0.0%
FY 2018 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2018 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2018 5y median 0.0% FY 2025
ROE -113.4%
FY 2018 5y median -52.5% FY 2025
ROIC -110.9%
FY 2018 5y median -52.1% FY 2025
ROA -92.1%
FY 2018 5y median -45.9% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2018 FY 2025
Operating Income 29.6%
FY 2018 FY 2025
EPS (diluted) 30.4%
FY 2018 FY 2025
Free Cash Flow 17.5%
FY 2018 FY 2025
Financial Health
Current Ratio 5.1×
FY 2018 5y median 11.9× FY 2025
Quick Ratio 5.1×
FY 2018 5y median 11.9× FY 2025
Debt / Equity 0.1×
FY 2018 5y median 0.1× FY 2025
Net Debt / EBITDA 0.3×
FY 2018 5y median 0.2× FY 2025
Interest Coverage -697×
FY 2018 5y median -257× FY 2025
Dividends
Dividend Yield 0.0%
FY 2018 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2018 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31